As a subsidiary of Intrexon Corporation, Triple-Gene is a clinical stage gene therapy company focused on developing advanced therapies for complex cardiovascular diseases. They have developed several multi-genic solutions which enable the reprogramming of cells and organs toward a positive state of health. The work they are doing is truly remarkable and it has been our privilege to partner with them in crafting the brand identity and developing the website for this groundbreaking company.


Developing advanced therapies for complex cardiovascular diseases.
As a subsidiary of Intrexon Corporation, Triple-Gene is a clinical stage gene therapy company focused on developing advanced therapies for complex cardiovascular diseases. They have developed several multi-genic solutions which enable the reprogramming of cells and organs toward a positive state of health. The work they are doing is truly remarkable and it has been our privilege to partner with them in crafting the brand identity and developing the website for this groundbreaking company.





”Thank you for the exceptional work that you and your team performed under incredibly tight timelines. I am highly impressed by the efficient and professional process you managed at every step of our engagement...
Thomas D. Reed, Ph.D.Founder & Chief Science Officer | Intrexon Corporation

